AU7541696A - A method of preparing vaccine compositions containing 3-0-deacylated monophosphoryl lipid A - Google Patents
A method of preparing vaccine compositions containing 3-0-deacylated monophosphoryl lipid AInfo
- Publication number
- AU7541696A AU7541696A AU75416/96A AU7541696A AU7541696A AU 7541696 A AU7541696 A AU 7541696A AU 75416/96 A AU75416/96 A AU 75416/96A AU 7541696 A AU7541696 A AU 7541696A AU 7541696 A AU7541696 A AU 7541696A
- Authority
- AU
- Australia
- Prior art keywords
- compositions containing
- vaccine compositions
- monophosphoryl lipid
- deacylated monophosphoryl
- preparing vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9306029 | 1993-03-23 | ||
GB939306029A GB9306029D0 (en) | 1993-03-23 | 1993-03-23 | Vaccine compositions |
GB9403417A GB9403417D0 (en) | 1994-02-23 | 1994-02-23 | Vaccine compositions |
GB9403417 | 1994-02-23 | ||
AU64264/94A AU685443B2 (en) | 1993-03-23 | 1994-03-14 | Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64264/94A Division AU685443B2 (en) | 1993-03-23 | 1994-03-14 | Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7541696A true AU7541696A (en) | 1997-02-13 |
AU705739B2 AU705739B2 (en) | 1999-06-03 |
Family
ID=27155521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75416/96A Ceased AU705739B2 (en) | 1993-03-23 | 1996-12-18 | A method of preparing vaccine compositions containing 3-0-deacylated monophosphoryl lipid A |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU705739B2 (en) |
-
1996
- 1996-12-18 AU AU75416/96A patent/AU705739B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU705739B2 (en) | 1999-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL310598A1 (en) | Composition of vaccines containing 3-0-deacylated monophosphoryl lipoid a | |
AU4662393A (en) | Use of gm-csf as a vaccine adjuvant | |
AU6445796A (en) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A | |
AU2455092A (en) | Method of preparing sunscreens | |
HUP0001403A3 (en) | Aqueous immunologic adjuvant compositions of monophosphoryl lipid a | |
AU1012897A (en) | Method of preparing optically pure precursors of paroxetine | |
AU8806191A (en) | Preparation of alkoxyalkanoic acids | |
AU3676393A (en) | Process for the preparation of a biphenyl derivative | |
AU4259296A (en) | Process for preparation of supports | |
AU1906097A (en) | A method of preparing a composition containing a high amount of ganglioside | |
AU7541696A (en) | A method of preparing vaccine compositions containing 3-0-deacylated monophosphoryl lipid A | |
AU5643594A (en) | Process for the preparation of organochlorosilanes | |
AU3614493A (en) | Non-toxic lipid vaccine formulations | |
AU3350489A (en) | Process for the preparation of alkyl 3-alkoxypropionates | |
AU3298195A (en) | A method of preparing ganglioside | |
AU1510192A (en) | Preparation process of alpha-aspartyl-l-phenylalanine methyl ester | |
AU5615294A (en) | Process for preparing diesters of naphthalenedicarboxylic acids | |
AU3298295A (en) | A method of preparing ganglioside | |
AU4187389A (en) | Method for preparing tpa compositions | |
AU1890695A (en) | Process for preparing fatty acid esters of alkyl glycosides | |
AU2406795A (en) | Process for the preparation of bis(amidocarboxylic acids) | |
AU6244094A (en) | Method of enhancing immune response to oral vaccines | |
AU1297492A (en) | Method of preparing polyethercyclicpolyols | |
AU1297592A (en) | Method of preparing polyethercyclicopolyols | |
AU2347188A (en) | Preparation method of alpha-l-aspartyl-l-phenylalanine methyl ester having improved solubilization |